CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,871 | -30.7% | 30,435 | +5.7% | 0.00% | -100.0% |
| Q2 2023 | $300,096 | +31.2% | 28,800 | -12.3% | 0.00% | 0.0% |
| Q1 2023 | $228,790 | +16.4% | 32,825 | +6.6% | 0.00% | 0.0% |
| Q4 2022 | $196,510 | +106.9% | 30,801 | +154.3% | 0.00% | – |
| Q3 2022 | $95,000 | -42.4% | 12,112 | -0.3% | 0.00% | -100.0% |
| Q2 2022 | $165,000 | +6.5% | 12,151 | +54.0% | 0.00% | 0.0% |
| Q1 2022 | $155,000 | -37.2% | 7,888 | +12.7% | 0.00% | 0.0% |
| Q4 2021 | $247,000 | +69.2% | 7,002 | +162.5% | 0.00% | 0.0% |
| Q3 2021 | $146,000 | -25.5% | 2,667 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $196,000 | – | 2,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |